135 related articles for article (PubMed ID: 808157)
21. Adaptation to sulfonamide resistance in Neisseria meningitidis may have required compensatory changes to retain enzyme function: kinetic analysis of dihydropteroate synthases from N. meningitidis expressed in a knockout mutant of Escherichia coli.
Fermér C; Swedberg G
J Bacteriol; 1997 Feb; 179(3):831-7. PubMed ID: 9006040
[TBL] [Abstract][Full Text] [Related]
22. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum.
Triglia T; Menting JG; Wilson C; Cowman AF
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13944-9. PubMed ID: 9391132
[TBL] [Abstract][Full Text] [Related]
23. Nutritional requirement for 4-aminobenzoate caused by mutation of dihydropteroate synthetase.
Rappold H; Bacher A
Z Naturforsch C Biosci; 1976; 31(5-6):285-7. PubMed ID: 134570
[TBL] [Abstract][Full Text] [Related]
24. R-factor-mediated resistance to sulfonamides by a plasmid-borne, drug-resistant dihydropteroate synthase.
Sköld O
Antimicrob Agents Chemother; 1976 Jan; 9(1):49-54. PubMed ID: 769673
[TBL] [Abstract][Full Text] [Related]
25. Point mutations in the dihydropteroate synthase gene causing sulfonamide resistance.
Swedberg G; Fermér C; Sköld O
Adv Exp Med Biol; 1993; 338():555-8. PubMed ID: 8304179
[No Abstract] [Full Text] [Related]
26. P-Aminobenzoic acid derivatives as inhibitors of the cell-free H2-pteroate synthesizing system of Escherichia coli.
Thijssen HH
J Med Chem; 1977 Feb; 20(2):233-6. PubMed ID: 319235
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationships in dihydropteroate synthase inhibition by sulfanilamides. Comparison with the antibacterial activity.
De Benedetti PG; Rastelli A; Frassineti C; Cennamo C
J Med Chem; 1981 Apr; 24(4):454-7. PubMed ID: 7021831
[TBL] [Abstract][Full Text] [Related]
28. Identification of a class of sulfonamides highly active against dihydropteroate synthase form Toxoplasma gondii, Pneumocystis carinii, and Mycobacterium avium.
Chio LC; Bolyard LA; Nasr M; Queener SF
Antimicrob Agents Chemother; 1996 Mar; 40(3):727-33. PubMed ID: 8851601
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action.
Baca AM; Sirawaraporn R; Turley S; Sirawaraporn W; Hol WG
J Mol Biol; 2000 Oct; 302(5):1193-212. PubMed ID: 11007651
[TBL] [Abstract][Full Text] [Related]
30. Sulphonamide resistant commensal Neisseria with alterations in the dihydropteroate synthase can be isolated from carriers not exposed to sulphonamides.
Qvarnström Y; Swedberg G
BMC Microbiol; 2002 Nov; 2():34. PubMed ID: 12435277
[TBL] [Abstract][Full Text] [Related]
31. Computational insights into factor affecting the potency of diaryl sulfone analogs as Escherichia coli dihydropteroate synthase inhibitors.
Das BK; Pv P; Chakraborty D
Comput Biol Chem; 2019 Feb; 78():37-52. PubMed ID: 30497019
[TBL] [Abstract][Full Text] [Related]
32. Characterization of different plasmid-borne dihydropteroate synthases mediating bacterial resistance to sulfonamides.
Swedberg G; Sköld O
J Bacteriol; 1980 Apr; 142(1):1-7. PubMed ID: 6989796
[TBL] [Abstract][Full Text] [Related]
33. Plasmid-mediated sulfonamide resistance in Neisseria meningitidis.
Facinelli B; Varaldo PE
Antimicrob Agents Chemother; 1987 Oct; 31(10):1642-3. PubMed ID: 3124735
[TBL] [Abstract][Full Text] [Related]
34. Monocyclic pteridine analogues. Inhibition of Escherichia coli dihydropteroate synthase by 6-amino-5-nitrosoisocytosines.
Lever OW; Bell LN; McGuire HM; Ferone R
J Med Chem; 1985 Dec; 28(12):1870-4. PubMed ID: 3906132
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of bi-substrate state mimics of dihydropteroate synthase as potential inhibitors and molecular probes.
Qi J; Virga KG; Das S; Zhao Y; Yun MK; White SW; Lee RE
Bioorg Med Chem; 2011 Feb; 19(3):1298-305. PubMed ID: 21216602
[TBL] [Abstract][Full Text] [Related]
36. Sulfonamide resistance mechanism in Escherichia coli: R plasmids can determine sulfonamide-resistant dihydropteroate synthases.
Wise EM; Abou-Donia MM
Proc Natl Acad Sci U S A; 1975 Jul; 72(7):2621-5. PubMed ID: 1101260
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of dihydropteroate synthase: substituent effects in the side-chain aromatic ring of 6-[[3-(aryloxy)propyl]amino]-5-nitrosoisocytosines and synthesis and inhibitory potency of bridged 5-nitrosoisocytosine-p-aminobenzoic acid analogues.
Lever OW; Bell LN; Hyman C; McGuire HM; Ferone R
J Med Chem; 1986 May; 29(5):665-70. PubMed ID: 3486292
[TBL] [Abstract][Full Text] [Related]
38. Toxoplasma gondii: characterization of a mutant resistant to sulfonamides.
Pfefferkorn ER; Borotz SE; Nothnagel RF
Exp Parasitol; 1992 May; 74(3):261-70. PubMed ID: 1582478
[TBL] [Abstract][Full Text] [Related]
39. Characterization of mutationally altered dihydropteroate synthase and its ability to form a sulfonamide-containing dihydrofolate analog.
Swedberg G; Castensson S; Sköld O
J Bacteriol; 1979 Jan; 137(1):129-36. PubMed ID: 368012
[TBL] [Abstract][Full Text] [Related]
40. Inhibition studies of sulfonamide-containing folate analogs in yeast.
Patel O; Satchell J; Baell J; Fernley R; Coloe P; Macreadie I
Microb Drug Resist; 2003; 9(2):139-46. PubMed ID: 12820798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
